04:14 PM EST, 03/07/2025 (MT Newswires) -- Kate Haviland, Chief Executive Officer, on March 05, 2025, sold 16,151 shares in Blueprint Medicines ( BPMC ) for $1,434,209. Following the Form 4 filing with the SEC, Haviland has control over a total of 168,427 common shares of the company, with 168,427 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1597264/000141588925007384/xslF345X05/form4-03072025_090351.xml